Standard Life Euro Pri Eqty Tst PLC Estimated Net Asset Value as at 31 July 2016 (8230G)
12 August 2016 - 4:00PM
UK Regulatory
TIDMSEP
RNS Number : 8230G
Standard Life Euro Pri Eqty Tst PLC
12 August 2016
12 August 2016
STANDARD LIFE EUROPEAN PRIVATE EQUITY TRUST PLC ("SLEPET" OR
"THE COMPANY") ANNOUNCES ITS ESTIMATED NET ASSET VALUE ("NAV") AT
31 JULY 2016
-- ESTIMATED NAV AT 31 JULY 2016 WAS 325.4 PENCE PER SHARE
(ESTIMATED NAV AT 30 JUNE 2016 WAS 323.6 PENCE PER SHARE)
-- SLEPET RECEIVED GBP7.8 MILLION OF DISTRIBUTIONS AND PAID
GBP4.7 MILLION OF DRAW DOWNS DURING THE MONTH OF JULY
-- OUTSTANDING COMMITMENTS OF GBP313.3 MILLION AT 31 JULY 2016
SLEPET's valuation policy for private equity funds is based on
the latest valuations reported by the managers of the funds in
which the Company has interests. In the case of SLEPET's valuation
at 31 July 2016, 98.3% of the reported portfolio valuations were
dated 31 March 2016.
Estimated NAV
At 31 July 2016, SLEPET's estimated NAV was 325.4 pence per
share (estimated net assets GBP503.7 million), representing a 0.6%
per share increase from the estimated NAV at 30 June 2016 of 323.6
pence per share (estimated net assets GBP500.8 million). The 1.8
pence increase in NAV primarily reflected unrealised foreign
exchange gains arising from a 1.3% appreciation in the euro versus
sterling during July, partially offset by the interim dividend
payment of 1.8 pence per share on 15 July 2016. The cash cost of
the final dividend was GBP2.8 million.
Draw downs and distributions
SLEPET received GBP7.8 million of distributions and paid GBP4.7
million of draw downs during the month. The distributions received
generated net realised gains and income of GBP1.4 million.
Commitments
The Company had GBP313.3 million of outstanding commitments at
31 July 2016. After undertaking a detailed review, the Manager
continues to believe that up to GBP55 million of the Company's
existing outstanding commitments are unlikely to be drawn.
Balance sheet and credit facility
The Company had liquid resources of GBP111.7 million at 31 July
2016. In addition, the Company has an undrawn GBP80 million
syndicated revolving credit facility, provided by Citibank and
Societe Generale that expires in December 2020.
Brexit
The Board of the Company and the Manager are monitoring closely
the impact of the UK referendum vote to leave the EU and the
consequences this may have on the Company's portfolio and
investment strategy. In particular, the Manager will be analysing
the 30 June 2016 valuations from underlying managers as they become
available.
SLEPET's investment strategy is to invest in the leading
European private equity fund managers. At 31 March 2016, 85% of
SLEPET's underlying portfolio companies, by value, were
headquartered outside the UK, predominately in continental European
mid to large cap businesses. In addition, the Company has
approximately GBP112 million of liquid resources which should mean
that the Company is well placed to take advantage of any market
dislocation via secondary market purchases.
Future announcements
The Company is expecting to announce its actual NAV at 30 June
2016 on 29 September 2016 and will announce its estimated NAV at 31
August 2016 at the same time.
Additional detail about SLEPET's NAV and investment
diversification can be found on SLEPET's website. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website is incorporated
into, or forms part of, this announcement.
For further information please contact Roger Pim or Peter
McKellar at SL Capital Partners LLP (0131 245 0055)
Note:-
Standard Life European Private Equity Trust PLC is an investment
company managed by SL Capital Partners LLP, the ordinary shares of
which are admitted to listing by the UK Listing Authority and to
trading on the Stock Exchange and which seeks to conduct its
affairs so as to qualify as an investment trust under sections
1158-1165 of the Corporation Tax Act 2010. The Board of Standard
Life European Private Equity Trust PLC is independent of Standard
Life plc.
Valuation Methodology
Unquoted investments are stated at the directors' estimate of
fair value and follow the recommendations of EVCA and BVCA. The
estimate of fair value is normally the latest valuation placed on a
fund by its manager at the balance sheet date. The valuation
policies used by the manager in undertaking that valuation will
generally be in line with the joint publication from EVCA and BVCA,
'International Private Equity and Venture Capital Valuation
guidelines'. Where formal valuations are not completed at the
balance sheet date the last available valuation from the fund
manager is adjusted for any subsequent cashflows occurring between
the valuation date and the balance sheet date. The Company's
Manager may further adjust such valuations to reflect any changes
in circumstances from the last manager's formal valuation date to
arrive at the estimate of fair value. Quoted investments are valued
based on quoted prices as of the last day of the relevant
period.
The Company intends to release regular estimated NAV updates
around ten business days after each month end, while continuing to
issue quarterly trading statements. A breakdown of SLEPET's
portfolio can be obtained in the latest monthly factsheet, which is
published on the Manager's website at
www.slcapital.com/IT_European_Private_Equity/getLatest.pdf
This information is provided by RNS
The company news service from the London Stock Exchange
END
NAVAKKDQDBKDPFD
(END) Dow Jones Newswires
August 12, 2016 02:00 ET (06:00 GMT)
Abrdn Private Equity Opp... (LSE:APEO)
Historical Stock Chart
From Apr 2024 to May 2024
Abrdn Private Equity Opp... (LSE:APEO)
Historical Stock Chart
From May 2023 to May 2024